High Court to Review Teva Appeal in Copaxone Case

The U.S. Supreme Court agreed to consider a Teva Pharmaceutical Industries appeal of a ruling that invalidated a company patent on its blockbuster multiple-sclerosis drug Copaxone.



from WSJ.com: US Business http://ift.tt/1ggwtqD

via IFTTT